We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+1.54%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$9.09B
AUM Growth
-$257M
Cap. Flow
-$296M
Cap. Flow %
-3.26%
Top 10 Hldgs %
15.99%
Holding
2,485
New
64
Increased
214
Reduced
993
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 16.97%
2 Financials 14.88%
3 Healthcare 12.5%
4 Industrials 10.33%
5 Consumer Discretionary 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPTX
2051
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$165K ﹤0.01%
4,396
LXFR icon
2052
Luxfer Holdings
LXFR
$457M
$165K ﹤0.01%
+10,598
New +$195K
EZPW icon
2053
Ezcorp Inc
EZPW
$1.76B
$165K ﹤0.01%
25,543
PDLI
2054
DELISTED
PDL BioPharma, Inc.
PDLI
$164K ﹤0.01%
76,001
KDMN
2055
DELISTED
Kadmon Holdings, Inc.
KDMN
$164K ﹤0.01%
65,134
+14,934
+30% +$37.1K
CRCM
2056
DELISTED
CARE.COM, INC.
CRCM
$164K ﹤0.01%
15,699
CAMP
2057
DELISTED
CalAmp Corp.
CAMP
$164K ﹤0.01%
619
CDMO
2058
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$164K ﹤0.01%
30,862
CTO
2059
CTO Realty Growth
CTO
$823M
$163K ﹤0.01%
9,155
TBBK icon
2060
The Bancorp
TBBK
$2.82B
$163K ﹤0.01%
16,456
-9,291
-36% -$88.3K
RES icon
2061
RPC Inc
RES
$1.39B
$163K ﹤0.01%
29,038
FRPH icon
2062
FRP Holdings
FRPH
$425M
$163K ﹤0.01%
6,778
BSTC
2063
DELISTED
BioSpecifics Technologies Corp.
BSTC
$162K ﹤0.01%
3,035
ATEX icon
2064
Anterix
ATEX
$1.79B
$162K ﹤0.01%
4,481
COLL icon
2065
Collegium Pharmaceutical
COLL
$913M
$161K ﹤0.01%
14,032
TBIO
2066
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$160K ﹤0.01%
16,186
DSSI
2067
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
$160K ﹤0.01%
+14,552
New +$167K
WLDN icon
2068
Willdan Group
WLDN
$1.29B
$160K ﹤0.01%
4,570
GOGO icon
2069
Gogo Inc
GOGO
$377M
$160K ﹤0.01%
26,493
-365
-1% -$1.72K
GNMK
2070
DELISTED
GenMark Diagnostics, Inc
GNMK
$160K ﹤0.01%
26,350
MDR
2071
DELISTED
McDermott International
MDR
$159K ﹤0.01%
78,718
-107,625
-58% -$661K
CYH icon
2072
Community Health Systems
CYH
$419M
$158K ﹤0.01%
44,002
+361
+0.8% +$941
CCBG icon
2073
Capital City Bank Group
CCBG
$898M
$158K ﹤0.01%
5,769
CATC
2074
DELISTED
CAMBRIDGE BANCORP
CATC
$158K ﹤0.01%
2,103
NEX
2075
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$157K ﹤0.01%
25,842

Similar funds

MetLife Investment Management's Q3 2019 Portfolio in Review

As of Q3 2019, MetLife Investment Management held 2,485 positions worth $9.09B, down 2.8% from $9.35B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

MetLife Investment Management withdrew a net $296M in Q3 2019, closing 157 positions and reducing 993 holdings. Its most notable exit was Anadarko Petroleum, an estimated $9.77M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in T-Mobile US worth $6.78M.

  • MetLife Investment Management's largest Q3 2019 buy was T-Mobile US: 86,035 shares worth $6.78M.
  • MetLife Investment Management added most to Fidelity National Information Services in Q3 2019, an estimated $10.3M increase.
  • MetLife Investment Management's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $66.2M.
  • MetLife Investment Management fully exited Anadarko Petroleum in Q3 2019, selling an estimated $9.77M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $9.09B portfolio in Q3 2019.
  • MetLife Investment Management opened 64 new positions and closed 157 in Q3 2019.
  • MetLife Investment Management's portfolio value fell 2.8% quarter-over-quarter to $9.09B.

Based on MetLife Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.